Toxic epidermal necrolysis and Stevens-Johnson syndrome at the Prague Burn Centre 1998-2008

Journal of the European Academy of Dermatology and Venereology

Volumn 26, Issue 5, 2012, Pages 639-643

  Zajicek, R ^a   Pintar, D ^b   Broz, L ^a   Suca, H ^a   Konigova R ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Hospital Havlickuv Brod   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ADOLESCENT; ADULT; ARTICLE; BODY SURFACE; CLINICAL ARTICLE; COMORBIDITY; CORTICOSTEROID THERAPY; EPITHELIZATION; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MALE; MORTALITY; PRIORITY JOURNAL; SEX RATIO; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; TREATMENT DURATION;

BURN UNITS; CZECH REPUBLIC; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; HUMANS; MALE; STEVENS-JOHNSON SYNDROME;

EID: 84860225189     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2011.04143.x     Document Type: Article

References (22)

1. Lissia M, Mules P, Bulla A, Rubino C,. Toxic epidermal necrolysis (Lyell's disease). Burns 2010; 36: 152-163.
2. Ducic I, Shalom A, Rising W, Nagamoto K, Munster AM,. Outcome of patients with toxic epidermal necrolysis syndrome revisited. Plast Reconstr Surg 2002; 110: 768-773.
3. Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P,. SCORTEN: a severity-of illness score for toxic epidermal necrolysis. J Invest Dermatol 2000; 115: 149-153. (Pubitemid 30637181)
4. Guégan S, Bastuji-Garin S, Poszepczynska-Guigné E, Roujeau JC, Revuz J,. Performance of the SCORTEN during the first five days of hospitalization to predict the prognosis of epidermal necrolysis. J Invest Dermatol 2006; 126: 272-276. (Pubitemid 43323160)
5. Chave TA, Mortimer NJ, Sladden MJ, Hall AP, Hutchinson PE,. Toxic epidermal necrolysis: current evidence, practical management and future directions. Br J Dermatol 2005; 153: 241-253. (Pubitemid 41228420)
6. Khalili B, Bahna SL,. Pathogenesis and recent therapeutic trends in Stevens-Johnson syndrome and toxic epidermal necrolysis. Ann Allergy Asthma Immunol 2006; 97: 272-281. (Pubitemid 44476560)
7. Palmieri TL, Greenhalgh DG, Saffle JR, et al. A multicenter review of toxic epidermal necrolysis treated in U.S. burn centers at the end of the twentieth century. J Burn Care Rehabil 2002; 23: 87-96. (Pubitemid 34242508)
8. Prins C, Kerdel FA, Padilla RS, et al. Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases. Arch Dermatol 2003; 139: 26-32. (Pubitemid 36091570)
9. Brown KM, Silver GM, Halerz M, Walaszek P, Sandroni A, Gamelli RL,. Toxic epidermal necrolysis: does immunoglobulin make a difference? J Burn Care Rehabil 2004; 25: 81-88. (Pubitemid 38116760)
10. Stella M, Clemente A, Bollero D, Risso D, Dalmasso P,. Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS): experience with high-dose intravenous immunoglobulins and topical conservative approach. A retrospective analysis. Burns 2007; 33: 452-459. (Pubitemid 46702386)
11. Königova R, Blaha J., Komplexní léčba popáleninového traumatu, Publishers Karolinum, Prague 2010.
12. Herndon DN., Total Burn Care, Elsevier 2007, Philadelphia, USA.
13. ® in the treatment of superficial scald burns in children. Burns 2011; 37: 333-337.
14. Parsons JM., Toxic epidermal necrolysis. Int J Dermatol 1992; 31: 749-768.
15. Kelemen JJ III, Cioffi WG, McManus WF, Mason AD Jr, Pruitt BA Jr,. Burn center care for patients with toxic epidermal necrolysis. J Am Coll Surg 1995; 180: 273-278.
16. McGee T, Munster A., Toxic epidermal necrolysis syndrome: mortality rate reduced with early referral to regional burncenter. Plast Reconstr Surg 1998; 102: 1018-1022. (Pubitemid 28414625)
17. Broz L, Königová R,. Topical antibacterial agents in the treatment of burns. Rozhl Chir 1986; 65: 791.
18. Engelhardt SL, Schurr MJ, Helgerson RB,. Toxic epidermal necrolysis: an analysis of referral patterns and steroid usage. J Burn Care Rehabil 1997; 18: 520-524. (Pubitemid 27508548)
19. Schneck J, Fagot J, Sekula P, Sassolas B, Roujeau JC, Mockenhaupt M,. Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR Study. J Am Acad Dermatol 2008; 58: 33-40. (Pubitemid 350298143)
20. Samimi SS, Siegfried E., Stevens-Johnson syndrome developing in a girl with systemic lupus erythematosus on high-dose corticosteroid therapy. Pediatr Dermatol 2002; 19: 52-55. (Pubitemid 34233566)
21. Schulz JT, Sheridan RL, Ryan CM, MacKool B, Tompkins RG,. A 10-year experience with toxic epidermal necrolysis. J Burn Care Rehabil 2000; 21: 199-204. (Pubitemid 30396349)
22. Shun-yuen Ying, Wai-sun Ho, Henry L Chan,. Toxic epidermal necrolysis: 10 years experience of a burns centre in Hon Kong. Burns 2001; 27: 371-375.